The annual general meeting directly elects the chair and vice chair of the Board of Directors of Novo Nordisk A/S. In March 2020, the Annual General Meeting re-elected Helge Lund as chair and re-elected Jeppe Christiansen as vice chair. Helge Lund was elected as chair in 2017 and Jeppe Christiansen was elected as vice chair in connection with his first election in 2013.
The Chairmanship assists the Board of Directors in the planning of Board meetings, employment of Executive Management and other assignments as decided by the Board.
The chair is considered independent and the vice chair is considered non-independent, as he is a board member of the main shareholder, Novo Holdings A/S.
In 2019, the Chairmanship conducted eight meetings. The chair attended all meetings in 2019 and the vice chair was excused from two meetings in 2019. Please refer to the Annual Report 2019 on p. 39 for a detailed attendance overview for the Chairmanship.
The Chairmanship works according to an Annual Work Plan with fixed agenda items. In addition, the Chairmanship requests ad hoc topics to be discussed at their meetings.
In 2019, the Chairmanship met eight times and dealt with the
Board matters and governance